[HTML] nih.gov

[HTML][HTML] Personalising medicine in inflammatory bowel disease—current and future perspectives

JJ Ashton, E Mossotto, S Ennis… - Translational …, 2019 - ncbi.nlm.nih.gov
Up to 25% of inflammatory bowel disease (IBD) presents during childhood, often with severe
and extensive disease, leading to significant morbidity including delayed growth and …
被引用次数：63 相关文章

Personalising medicine in inflammatory bowel disease-current and future perspectives

JJ Ashton, E Mossotto, S Ennis… - Translational …, 2019 - pubmed.ncbi.nlm.nih.gov
Up to 25% of inflammatory bowel disease (IBD) presents during childhood, often with severe
and extensive disease, leading to significant morbidity including delayed growth and …

Personalising medicine in inflammatory bowel disease-current and future perspectives.

JJ Ashton, E Mossotto, S Ennis… - Translational Pediatrics, 2019 - europepmc.org
Up to 25% of inflammatory bowel disease (IBD) presents during childhood, often with severe
and extensive disease, leading to significant morbidity including delayed growth and …

Personalising medicine in inflammatory bowel disease—current and future perspectives

JJ Ashton, E Mossotto, S Ennis… - Translational …, 2019 - tp.amegroups.org
Up to 25% of inflammatory bowel disease (IBD) presents during childhood, often with severe
and extensive disease, leading to significant morbidity including delayed growth and …

[引用][C] Personalising medicine in inflammatory bowel disease—current and future perspectives

JJ Ashton, E Mossotto, S Ennis… - Translational …, 2019 - eprints.soton.ac.uk
Personalising medicine in inflammatory bowel disease—current and future perspectives -
ePrints Soton The University of Southampton Courses University life Research Business Global …